CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft

American Journal of Roentgenology

Volumn 181, Issue 4, 2003, Pages 1125-1131

  Siegel, Marilyn J ^a   Lee, Edward Y ^a   Sweet, Stuart C ^b   Hildebolt, Charles ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; ESOPHAGUS DISEASE; ESOPHAGUS EROSION; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LUNG INFILTRATE; LUNG NODULE; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT INDICATION;

EID: 0141855093     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.4.1811125     Document Type: Article

References (28)

1. Hyashi RJ, Kraus MD, Patel AL, et al. Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior. J Pediatr Hematol Oncol 2001;23:14-18
2. Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 1996;8:139-148
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 1988;133:173-192
4. Boyle GJ, Michaels MG, Webber SA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 1997;131:309-313
5. Lim GY, Newman B, Kurland G, Webber SA. Posttransplantation lymphoproliferafive disorder: manifestation in pediatric thoracic organ recipients. Radiology 2002;222:699-708
6. Reyes J, Mazariegos GV. Pediatric transplantation. Surg Clin North Am 1999;79:163-189
7. Webber SA. 15 years of pediatric heart transplantation at the University of Pittsburgh: lessons learned and future prospects. Pediatr Transplant 1997;1:8-21
8. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders (PTLD): summary of Society for Hematopathology workshop. Semin Diagn Pathol 1997;14:8-14
9. Spray TL, Mallory GB, Canter CE, Huddleston CB. Pediatric lung transplantation: indications. techniques, and early results. J Thorac Cardiovasc Surg 1994;107:990-999
10. Sweet SC, Spray TL, Huddleston CB, et al. Pediatric lung transplantation at St. Louis Children's Hospital, 1990-1995. Am J Respir Crit Care Med 1997;155:1027-1035
11. Seiden MV, Sklar J. Molecular genetic analysis of post-transplant lymphoproliferative disorders. Hematol Oncol Clin North Am 1993;133:173-192
12. Nalesnik MA. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD). Springer Semin Immunopathol 1998;20:325-342
13. Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant 1998;2:56-63
14. Pickardt PJ, Siegel MJ, Hayashi RJ, Kelly M. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic and imaging features. Radiology 2000;217:16-25
15. Dror Y, Greenberg M, Taylor G, et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation 1999;67:990-998
16. Harmon WE, Dharnidharka VR. Lymphoproliferative diseases in children. Transplant Proc 1999;31:1268-1269
17. Newell KA, Alonso EM, Whitington PF, et al. Posttransplantation lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996;62:370-375
18. Pickhardt PJ, Siegel MJ, Anderson DC, Hayashi R, DeBaun MR. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients. AJR 1998;171:375-382
19. Armitage JM, Kormos RL, Stuart RS. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991;10:877-887
20. Donnelly LF, Frush DP, Marshall KW, White KS. Lymphoproliferative disorders: CT findings in immunocompromised children. AJR 1998;171:725-731
21. Billiar TR, Hanto DW, Simmons RL. Inclusion of infectious mononucleosis in the spectrum of Epstein-Barr virus infections in transplant recipients. Transplantation 1988;46:159-161
22. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Am J Surg Pathol 1990;14[suppl 1]:92-100
23. Pickhardt PJ, Siegel MJ. Abdominal manifestations of posttransplantation lymphoproliferative disorder. AJR 1998;171:1007-1013
24. Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder (PTLD) of the abdomen: CT evaluation in 51 patients. Radiology 1999;213:73-78
25. Rappaport DC, Chamberlain DW, Shepherd FA, Hutcheon MA. Lymphoproliferative disorders after lung transplantation: imaging features. Radiology 1998;206:519-524
26. Praghakaran K, Wise B, Chen A, Schwarz K, Colombani P. Rational management of posttransplant lymphoproliferative disorder in pediatric recipients. J Pediatr Surg 1999;34:112-116
27. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552-565
28. Chadburn A, Chen JM, Hsu DT, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferafive disorders are clinically relevant. Cancer 1998;82:1978-1987